Apollomics, Inc.

As of May 21, 2025, Apollomics, Inc. shows a mildly bearish trend due to daily moving averages indicating bearish momentum, despite some mildly bullish signals from the weekly MACD and KST, resulting in mixed signals overall.

Apollomics, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting no net profit and a market cap of $7.01 million. Key financial metrics indicate it is loss-making with a negative return on equity and no dividend yield.

As of Jun 18, Apollomics, Inc. has a market capitalization of 7.01 million and reported net sales of 0.00 million with a net profit of -0.83 million over the last four quarters. The balance sheet shows shareholder's funds of 4.86 million and total assets of 13.10 million.